<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04288180</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-48367</org_study_id>
    <nct_id>NCT04288180</nct_id>
  </id_info>
  <brief_title>Social Anxiety Virtual Reality Study</brief_title>
  <acronym>SAVR</acronym>
  <official_title>Maladaptive Avoidance and Fear Conditioning in Social Anxiety Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to validate a virtual reality paradigm that assesses maladaptive avoidance&#xD;
      behavior in social anxiety disorder. It also aims to generate a significant scientific&#xD;
      advance by testing the hypothesis that maladaptive avoidance maintains anxiety through&#xD;
      disruptions in safety learning.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although occasional mild social anxiety is a common human experience, social anxiety disorder&#xD;
      has a devastating impact on patients' lives, leaving them vulnerable to medical, psychiatric,&#xD;
      and socioeconomic complications. A key feature of social anxiety disorder is avoidance of&#xD;
      social and/or performance situations in which judgment and evaluation from others might&#xD;
      occur. Reducing avoidance is therefore an important treatment goal.&#xD;
&#xD;
      Despite the importance of avoidance, however, it is very difficult to assess a patient's&#xD;
      tendency to avoid. Many prior assessments of avoidance measure adaptive (i.e., helpful)&#xD;
      avoidance, in which an individual learns to avoid a truly noxious stimulus. However, anxiety&#xD;
      disorders are characterized by maladaptive avoidance, in which a relatively safe stimulus is&#xD;
      avoided resulting in interference with the individual's goals. In this study, the first aim&#xD;
      is to validate a virtual reality paradigm to measure maladaptive avoidance behavior in adults&#xD;
      with social anxiety disorder. The second aim is to test whether maladaptive avoidance&#xD;
      behavior relates to safety learning (measured by a fear extinction task).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    COVID-19 Pandemic&#xD;
  </why_stopped>
  <start_date type="Actual">January 15, 2020</start_date>
  <completion_date type="Actual">February 28, 2020</completion_date>
  <primary_completion_date type="Actual">February 28, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maladaptive Avoidance Behavior</measure>
    <time_frame>Baseline</time_frame>
    <description>Latency (in milliseconds) to enter the quadrant of the avoidance task containing the image from the fear learning task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maladaptive Avoidance Behavior (alternate measure)</measure>
    <time_frame>Baseline</time_frame>
    <description>Amount of time (in milliseconds) spent in the quadrant of the avoidance task containing the image from the fear learning task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maladaptive Avoidance Behavior (2nd alternate measure)</measure>
    <time_frame>Baseline</time_frame>
    <description>Amount of time (in milliseconds) with center of gaze on the image from the fear learning task</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">4</enrollment>
  <condition>Social Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>Social Anxiety Disorder</arm_group_label>
    <description>A group of adults with social anxiety disorder will be recruited for a psychological/behavioral research study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>There will be no intervention in this study. Adults with social anxiety disorder will complete research assessments related to fear and safety learning.</description>
    <arm_group_label>Social Anxiety Disorder</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with primary social anxiety disorder, community sample&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18+&#xD;
&#xD;
          -  primary diagnosis of social anxiety disorder&#xD;
&#xD;
          -  fluent spoken and written English&#xD;
&#xD;
          -  able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of manic episode, hypomanic episode, or psychosis&#xD;
&#xD;
          -  moderate or severe substance use disorder in the past 12 months&#xD;
&#xD;
          -  current major depressive episode greater than moderate severity (PHQ-9 score &gt;14)&#xD;
&#xD;
          -  high risk for suicide (&gt;8 on the MINI Suicidality section and/or clinician judgment&#xD;
             that immediate medical attention is necessary)&#xD;
&#xD;
          -  general medical condition or impediment to vision, hearing, or motor function likely&#xD;
             to interfere with assessments&#xD;
&#xD;
          -  benzodiazepine use in the past 2 weeks&#xD;
&#xD;
          -  cannabis use for anxiety management in the past 2 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 25, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Tali Manber Ball, PhD</investigator_full_name>
    <investigator_title>Instructor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Phobia, Social</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

